April 21, 2026
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
- Round
- Corporate Round
- Amount raised
- —
- Lead investor
- 5Y Capital
- Industry
- Alternative Medicine
- Headquarters
- Brisbane, United States
- Employees
- 11-50
- Website
- www.revirtx.com
- View profile →
Other investors
- California Institute for Regenerative Medicine
- CDH Investments
- CMT Research Foundation
- Cure CMT
- Lapam Capital
Source: Crunchbase snapshot 2026-05-15